Latest news - Johnson & Johnson
Find out the latest news and updates from Johnson & Johnson, a global healthcare company. Learn about its products, innovations, initiatives, earnings, and more.
Press Releases - Johnson & Johnson
3 days ago · Explore all Johnson & Johnson published press releases by date and/or topic of news
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
Sep 21, 2021 · Johnson & Johnson announced new data confirming strong and long-lasting protection of its single-shot COVID-19 vaccine in the U.S. and a booster shot further increased protection. The data were based on real-world evidence and Phase 3 studies and were submitted to regulators worldwide.
Latest COVID-19 News - Johnson & Johnson
Nov 30, 2021 · Latest news and press releases on Johnson & Johnson’s efforts to stem the COVID-19 pandemic.
News | Johnson & Johnson - Investors
3 days ago · You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact us with any questions or search this site for more information.
Johnson & Johnson: Changing health for humanity
3 days ago · Johnson & Johnson is a global healthcare company that develops and provides innovative medicines, medical devices and consumer products. Learn about its therapeutic areas, MedTech solutions, sustainability initiatives and more.
Investor Relations | Johnson & Johnson
Find out the latest information on Johnson & Johnson's stock performance, dividends, free cash flow, and market share. Watch the webcast of the third quarter 2024 earnings call and see the investor events and news.
Media Center - Johnson & Johnson
Oct 15, 2010 · Find the latest news, press releases and media assets from Johnson & Johnson, a global healthcare company. Learn about its innovative medicine and medical technologies, financial results and social impact.
Johnson & Johnson Reports Q1 2023 Results
Apr 18, 2023 · Johnson & Johnson Reports Q1 2023 Results 2023 First-Quarter reported sales growth of 5.6% to $24.7 Billion with operational growth of 9.0%* and adjusted operational growth of 7.6%* 2023 First-Quarter basic loss per share of ($0.03) decreasing 101.6% due to a special one-time charge, with adjusted earnings per share (EPS) of $2.68 increasing by ...
Positive New Data for Johnson & Johnson Single-Shot COVID-19 …
Jul 1, 2021 · The Company announced positive data on its single-shot vaccine's activity against the Delta variant and durability of response. The vaccine was 85 percent effective against severe/critical disease and generated neutralizing antibodies …